Shibi Likhite

5.0k citations
38 papers · 2.0k · 1 hit paper · h-index 16

Impact in

  • Neurology top 1%
    • Amyotrophic Lateral Sclerosis Research
    • Neuroinflammation and Neurodegeneration Mechanisms
    • Parkinson's Disease Mechanisms and Treatments
  • Genetics top 1%
    • Neurogenetic and Muscular Disorders Research
    • Virus-based gene therapy research

Papers in

  • Molecular Biology 24
    • RNA modifications and cancer 8
    • CRISPR and Genetic Engineering 7
    • RNA regulation and disease 4
  • Genetics 23
    • Neurogenetic and Muscular Disorders Research 22
    • Virus-based gene therapy research 6
    • Genetics and Neurodevelopmental Disorders 4
Co-authors
Kathrin Meyer (37 shared papers)Brian K. Kaspar (21 shared papers)Lyndsey Braun (7 shared papers)Laura Ferraiuolo (7 shared papers)Kevin D. Foust (12 shared papers)Carlos J. Miranda (6 shared papers)Arthur H.M. Burghes (10 shared papers)Jerry R. Mendell (8 shared papers)
Journals
Molecular Therapy (6 papers)Molecular Therapy — Methods & Clinical Development (5 papers)Neurology (3 papers)Neuromuscular Disorders (2 papers)Proceedings of the National Academy of Sciences (2 papers)
Partner nations
United StatesUnited KingdomGermany

In The Last Decade

Shibi Likhite

37 papers receiving 2.0k citations

Shibi Likhite's Hit Papers

Astrocytes from familial and sporadic ALS patients are toxic to motor neurons 2011 · 616 citations
6160+5+10Years since publication200400600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

  • it has ≥500 total citations;
  • it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
  • it reaches the top citation threshold in at least one of its specific research topics.
  1. 2011 Nature Biotechnology

Peers

Shibi Likhite
Comparison fields: 5 of 73
  • Neurology 1.0k
  • Genetics 720
  • Neurology 342
  • Developmental Neuroscience 152
  • Cellular and Molecular Neuroscience 289
Replace Seung Chun with:
Seung Chun United States
Ritchie Ho United States
Georg Haase France
Michael L. Garcia United States
Chiara F. Valori Germany
Meraida Polak United States
P. Hande Özdi̇nler United States
Elke Bogaert Belgium
Matthew B. Harms United States
Asako Otomo Japan
Shibi Likhite relative to Seung Chun United States Seung Chun's profile →
Citations per field
00.5×1.5×2×
Seung Chun · 1×
Citations per year

Countries citing papers authored by Shibi Likhite

Since Specialization
Citations

This map shows the geographic impact of Shibi Likhite's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shibi Likhite with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shibi Likhite more than expected).

Fields of papers citing papers by Shibi Likhite

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shibi Likhite. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shibi Likhite. The network helps show where Shibi Likhite may publish in the future.

Co-authors

The 25 scholars most cited alongside Shibi Likhite, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shibi Likhite Line = papers co-authored together Shibi Likhite links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Astrocytes from familial and sporadic ALS patients are toxic to motor neurons
Nature Biotechnology ·Amanda Haidet-Phillips, Mark E. Hester, Carlos J. Miranda, Kathrin Meyer, Lyndsey Braun, (unknown), SungWon Song, Shibi Likhite, Matthew Murtha, Kevin D. Foust, (unknown), Amy Eagle, Anja Kammesheidt, Ashley Christensen, Jerry R. Mendell, Arthur H.M. Burghes, Brian K. Kaspar
Hit paper breakdown →		2011616
2
Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS
Proceedings of the National Academy of Sciences ·Kathrin Meyer, Laura Ferraiuolo, Carlos J. Miranda, Shibi Likhite, Sohyun L. McElroy, Samantha Renusch, Dara Ditsworth, Clotilde Lagier‐Tourenne, Richard Smith, John Ravits, Arthur H.M. Burghes, Pamela J. Shaw, Don W. Cleveland, Stephen J. Kolb, Brian K. Kaspar
2013270
3
Improving Single Injection CSF Delivery of AAV9-mediated Gene Therapy for SMA: A Dose–response Study in Mice and Nonhuman Primates
Molecular Therapy ·Kathrin Meyer, Laura Ferraiuolo, Leah Schmelzer, Lyndsey Braun, Vicki L. McGovern, Shibi Likhite, Olivia Michels, Alessandra Govoni, Julie C. Fitzgerald, Pablo Morales, Kevin D. Foust, Jerry R. Mendell, Arthur H.M. Burghes, Brian K. Kaspar
2014220
4
Therapeutic AAV9-mediated Suppression of Mutant SOD1 Slows Disease Progression and Extends Survival in Models of Inherited ALS
Molecular Therapy ·Kevin D. Foust, Desirée L. Salazar, Shibi Likhite, Laura Ferraiuolo, Dara Ditsworth, Hristelina Ilieva, Kathrin Meyer, Leah Schmelzer, Lyndsey Braun, Don W. Cleveland, Brian K. Kaspar
2013160
5
Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism
Proceedings of the National Academy of Sciences ·Laura Ferraiuolo, Kathrin Meyer, Thomas W. Sherwood, Jonathan Vick, Shibi Likhite, (unknown), Carlos J. Miranda, Lyndsey Braun, Paul R. Heath, Ricardo Pineda, Christine E. Beattie, Pamela J. Shaw, Candice C. Askwith, Dana M. McTigue, Brian K. Kaspar
2016150
6
Delayed Disease Onset and Extended Survival in the SOD1G93ARat Model of Amyotrophic Lateral Sclerosis after Suppression of Mutant SOD1 in the Motor Cortex
Journal of Neuroscience ·Gretchen M. Thomsen, Genevíève Gowing, Jessica Latter, Maximus Chen, Jean‐Philippe Vit, Kevin Staggenborg, Pablo Avalos, Mor R. Alkaslasi, Laura Ferraiuolo, Shibi Likhite, Brian K. Kaspar, Clive N. Svendsen
2014111
7
Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis
Nature Medicine ·SungWon Song, Carlos J. Miranda, Lyndsey Braun, Kathrin Meyer, (unknown), Laura Ferraiuolo, Shibi Likhite, Adam K. Bevan, Kevin D. Foust, Michael J. McConnell, Christopher M. Walker, Brian K. Kaspar
2016105
8
Optimization and validation of CAR transduction into human primary NK cells using CRISPR and AAV
Cell Reports Methods ·Meisam Naeimi Kararoudi, Shibi Likhite, Ezgi Elmas, Kenta Yamamoto, M. Schwartz, Kinnari Sorathia, Marcelo de Souza Fernandes Pereira, Yasemin Sezgin, Raymond D. Devine, Justin Lyberger, Gregory K. Behbehani, Nitin Chakravarti, Branden S. Moriarity, Kathrin Meyer, Dean A. Lee
202239
9
Translating SOD1 Gene Silencing toward the Clinic: A Highly Efficacious, Off-Target-free, and Biomarker-Supported Strategy for fALS
Molecular Therapy — Nucleic Acids ·Tommaso Iannitti, Joseph M. Scarrott, Shibi Likhite, Ian Coldicott, Katherine E. Lewis, Paul R. Heath, Adrian Higginbottom, Monika A. Myszczynska, Marta Milo, Guillaume M. Hautbergue, Kathrin Meyer, Brian K. Kaspar, Laura Ferraiuolo, Pamela J. Shaw, Mimoun Azzouz
201835
10
AAV9 Gene Therapy Increases Lifespan and Treats Pathological and Behavioral Abnormalities in a Mouse Model of CLN8-Batten Disease
Molecular Therapy ·Tyler B. Johnson, Katherine A. White, Jon J. Brudvig, Jacob T. Cain, Logan M. Langin, Melissa A. Pratt, Clarissa D. Booth, Derek Timm, Samantha S. Davis, Brandon L. Meyerink, Shibi Likhite, Kathrin Meyer, Jill M. Weimer
202034
11
Gene Therapy Corrects Brain and Behavioral Pathologies in CLN6-Batten Disease
Molecular Therapy ·Jacob T. Cain, Shibi Likhite, Katherine A. White, Derek Timm, Samantha S. Davis, Tyler B. Johnson, Cassandra Dennys-Rivers, Federica Rinaldi, Dario Motti, Sarah Corcoran, Pablo Morales, Christopher R. Pierson, Stephanie M. Hughes, Stella Y. Lee, Brian K. Kaspar, Kathrin Meyer, Jill M. Weimer
201929
12
Neurotoxic Astrocytes Directly Converted from Sporadic and Familial ALS Patient Fibroblasts Reveal Signature Diversities and miR-146a Theragnostic Potential in Specific Subtypes
Cells ·Cátia Gomes, Catarina Sequeira, Shibi Likhite, Cassandra N. Dennys, Stephen J. Kolb, Pamela J. Shaw, Ana Rita Vaz, Brian K. Kaspar, Kathrin Meyer, Dora Brites
202226
13
CD33 Targeting Primary CAR-NK Cells Generated By CRISPR Mediated Gene Insertion Show Enhanced Anti-AML Activity
Blood ·Meisam Naeimi Kararoudi, Shibi Likhite, Ezgi Elmas, M. Schwartz, Kinnari Sorathia, Kenta Yamamoto, Nitin Chakravarti, Branden S. Moriarity, Kathrin Meyer, Dean A. Lee
202023
14
480. Gene Therapy for Spinal Muscular Atrophy Type 1 Shows Potential to Improve Survival and Motor Functional Outcomes
Molecular Therapy ·Jerry R. Mendell, Samiah Al-Zaidy, Richard Shell, W. David Arnold, Louise R. Rodino‐Klapac, John T. Kissel, Thomas W. Prior, Carlos J. Miranda, Linda Lowes, Lindsay N. Alfano, Katherine Berry, Christopher Petek, Kathleen Church, Lyndsey Braun, Sarah Corcoran, Kathrin Meyer, Shibi Likhite, Arthur H.M. Burghes, Kevin D. Foust, Brian K. Kaspar
201617
15
Novel MECP2 gene therapy is effective in a multicenter study using two mouse models of Rett syndrome and is safe in non-human primates
Molecular Therapy ·Samantha K. Powers, Shibi Likhite, Kamal K.E. Gadalla, Carlos J. Miranda, Amy J. Huffenberger, Cassandra N. Dennys, Kevin D. Foust, Pablo Morales, Christopher R. Pierson, Federica Rinaldi, Stephanie T. Perry, Brad Bolon, Nicolas Wein, Stuart Cobb, Brian K. Kaspar, Kathrin Meyer
202317
16
AAV9-MCT8 Delivery at Juvenile Stage Ameliorates Neurological and Behavioral Deficits in a Mouse Model of MCT8-Deficiency
Thyroid ·Xiao-Hui Liao, Pablo Avalos, Oksana Shelest, Raz Ofan, Michael Shilo, Catherine Bresee, Shibi Likhite, Jean‐Philippe Vit, Heike Heuer, Brian K. Kaspar, Kathrin Meyer, Alexandra M. Dumitrescu, Samuel Refetoff, Clive N. Svendsen, Gad D. Vatine
202215
17
Intracranial delivery of AAV9 gene therapy partially prevents retinal degeneration and visual deficits in CLN6-Batten disease mice
Molecular Therapy — Methods & Clinical Development ·Katherine A. White, Hemanth R. Nelvagal, Timothy A. Poole, Bin Lü, Tyler B. Johnson, Samantha S. Davis, Melissa A. Pratt, Jon J. Brudvig, Ana B. Assis, Shibi Likhite, Kathrin Meyer, Brian K. Kaspar, Jonathan D. Cooper, Shaomei Wang, Jill M. Weimer
202113
18
Onasemnogene abeparvovec-xioi: a gene replacement strategy for thetreatment of infants diagnosed with spinal muscular atrophy
Drugs of today ·M. Schwartz, Shibi Likhite, Kathrin Meyer
202112
19
Optimization and Validation of CAR Transduction into Human Primary NK Cells Using CRISPR and AAV
SSRN Electronic Journal ·Meisam Naeimi Kararoudi, Shibi Likhite, Ezgi Elmas, Kenta Yamamoto, M. Schwartz, Kinnari Sorathia, Marcelo de Souza Fernandes Pereira, Raymond D. Devin, Justin Lyberger, Gregory K. Behbehani, Nitin Chakravarti, Branden S. Moriarity, Kathrin Meyer, Dean A. Lee
202111
20
Early postnatal administration of an AAV9 gene therapy is safe and efficacious in CLN3 disease
Frontiers in Genetics ·Tyler B. Johnson, Jon J. Brudvig, Shibi Likhite, Melissa A. Pratt, Katherine A. White, Jacob T. Cain, Clarissa D. Booth, Derek Timm, Samantha S. Davis, Brandon L. Meyerink, Ricardo Pineda, Cassandra Dennys-Rivers, Brian K. Kaspar, Kathrin Meyer, Jill M. Weimer
202311

About Shibi Likhite

Shibi Likhite is a scholar working on Molecular Biology, Genetics, Neurology, Genetics and Oncology, having authored 38 papers that have together received 2.0k indexed citations. Recurring topics across this work include Neurogenetic and Muscular Disorders Research (22 papers), Amyotrophic Lateral Sclerosis Research (10 papers), RNA modifications and cancer (8 papers), CRISPR and Genetic Engineering (7 papers), Virus-based gene therapy research (6 papers), Genetics and Neurodevelopmental Disorders (4 papers), Lysosomal Storage Disorders Research (4 papers) and RNA regulation and disease (4 papers). The work is most often cited by research in Neurology (1.0k citations), Genetics (720 citations), Neurology (342 citations), Developmental Neuroscience (152 citations) and Cellular and Molecular Neuroscience (289 citations). Shibi Likhite has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Kathrin Meyer, Brian K. Kaspar, Lyndsey Braun, Laura Ferraiuolo, Kevin D. Foust, Carlos J. Miranda, Arthur H.M. Burghes, Jerry R. Mendell, SungWon Song and Ashley Christensen. Their work appears in journals such as Molecular Therapy, Molecular Therapy — Methods & Clinical Development, Neurology, Neuromuscular Disorders and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seung ChunBreakdown of academic impact, for papers by Ritchie HoBreakdown of academic impact, for papers by Georg HaaseBreakdown of academic impact, for papers by Michael L. GarciaBreakdown of academic impact, for papers by Chiara F. ValoriBreakdown of academic impact, for papers by Meraida PolakBreakdown of academic impact, for papers by P. Hande Özdi̇nlerBreakdown of academic impact, for papers by Elke BogaertBreakdown of academic impact, for papers by Matthew B. HarmsBreakdown of academic impact, for papers by Asako Otomo